Monitoring of Rivaroxaban Therapy in Hypercoagulable Dogs
ABSTRACT Background Measurement of rivaroxaban efficacy using the rivaroxaban‐specific anti‐Xa assay (raXa) can be used for monitoring in veterinary medicine. Detection of rivaroxaban efficacy using other hemostatic tests would make monitoring timelier and more accessible. Objectives Compare results...
Saved in:
| Main Authors: | Erin M. Phillips, Shauna L. Blois, Anthony C. G. Abrams‐Ogg, R. Darren Wood, Gabrielle Monteith, Benoît Cuq |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Journal of Veterinary Internal Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/jvim.70014 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chromogenic anti-Xa test: the ratio between heparin activity units and concentration of apixaban and rivaroxaban
by: E. V. Titaeva, et al.
Published: (2020-12-01) -
Predictive thresholds of peak and trough anti-Xa levels for bleeding risk in rivaroxaban-treated nonvalvular atrial fibrillation
by: Mouhammad Rida Almouwannes, et al.
Published: (2025-08-01) -
Integrated laboratory coagulation tests in hypercoagulation diagnosis and thrombosis risk assessment. Part II. The sensitivity of integral tests to hypercoagulable states
by: E. N. Lipets, et al.
Published: (2015-10-01) -
ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES
by: Z. M. Safiullina, et al.
Published: (2015-09-01) -
Paralogism in the interpretation of thrombogram obtained with the thrombin generation assay of human blood plasma
by: Ye. M. Makogonenko, et al.
Published: (2025-02-01)